Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Planet 13 HoldingsPLNH -4.52%31 Days Sales Outstanding is 2.54 as of Jun. 2026, which is 38% below its 10-year median of 4.08. GuruFocus rates PLNH with a GF Score™ of 31/100 and a GF Value™ of $0.25 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 946 Drug Manufacturers companies, Planet 13 Holdings ranks better than 98.84% on this metric.
Planet 13 Holdings (OTCPK:PLNH) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Planet 13 Holdings Days Sales Outstanding Related Terms
Planet 13 Holdings Days Sales Outstanding Historical Data
* Premium members only.
The historical data trend for Planet 13 Holdings's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Planet 13 Holdings's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Planet 13 Holdings Days Sales Outstanding vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Planet 13 Holdings's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Planet 13 Holdings's Days Sales Outstanding falls into.
Planet 13 Holdings Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Planet 13 Holdings (PLNH) has a Days Sales Outstanding of 2.54 as of Jun. 2026. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Planet 13 Holdings and its competitors. This is 38% below median its historical median of 4.08. Over the past decade, Planet 13 Holdings' Days Sales Outstanding has ranged from 1.23 to 4.71. According to the industry distribution chart, Planet 13 Holdings ranks #11 out of 946 companies in the Drug Manufacturers industry, placing it in the top 1.2%.
Is Planet 13 Holdings' Days Sales Outstanding too high?
Planet 13 Holdings' current Days Sales Outstanding of 2.54 is 38% below median its 10-year median of 4.08. Over the past 10 years, this metric has ranged from a low of 1.23 to a high of 4.71. The Drug Manufacturers industry median Days Sales Outstanding is 71.96. Planet 13 Holdings' value of 2.54 is 96.5% below this industry median. Based on the distribution chart, Planet 13 Holdings ranks #11 out of 946 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Planet 13 Holdings has a GF Score™ of 31/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Planet 13 Holdings' Days Sales Outstanding compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Planet 13 Holdings ranks #11 out of 946 companies for Days Sales Outstanding. This places Planet 13 Holdings in the top 1% of its industry — outperforming the majority of peers. The industry median Days Sales Outstanding is 71.96. Planet 13 Holdings' value of 2.54 is 96.5% below this benchmark. Historically, Planet 13 Holdings' own Days Sales Outstanding has ranged from 1.23 to 4.71 over the past decade. While the company's 10-year median is 4.08 vs. the industry median of 71.96, Planet 13 Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Drug Manufacturers company?
The median Days Sales Outstanding among Drug Manufacturers companies is 71.96, based on 946 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Planet 13 Holdings's current Days Sales Outstanding of 2.54 is 96.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Planet 13 Holdings and its competitors. For the Drug Manufacturers industry, the median Days Sales Outstanding is 71.96 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Planet 13 Holdings's current Days Sales Outstanding is 2.54, which is 38% below median its own 10-year median of 4.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Planet 13 Holdings stock overvalued right now?
Based on GuruFocus' analysis, Planet 13 Holdings (PLNH) is currently considered Possible Value Trap. The stock's GF Value™ is $0.25, compared to a current price of $0.14 — trading 44.6% below its estimated fair value. The current Days Sales Outstanding is 2.54, which is 38% below median its 10-year median of 4.08 and 96.5% below the Drug Manufacturers industry median of 71.96. Planet 13 Holdings' overall GF Score™ is 31/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For Planet 13 Holdings (PLNH), the current Days Sales Outstanding is 2.54 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Planet 13 Holdings (PLNH) Overvalued in 2026?
Based on GuruFocus' analysis, Planet 13 Holdings stock appears to be undervalued.
The current stock price of $0.14 is trading 44.6% below its estimated GF Value™ of $0.25.
GuruFocus considers Planet 13 Holdings to be Possible Value Trap.
Key valuation signals for PLNH:
Days Sales Outstanding: 2.54 (38% below median its 10-year median of 4.08)
GF Value™: $0.25 vs. price of $0.14 (44.6% below fair value)
Industry Position: 96.5% below the Drug Manufacturers median (#11 of 946)
No single metric tells the full story. See the PLNH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Planet 13 Holdings Inc a vertically integrated cultivator and provider of cannabis and cannabis-infused products in the States of Nevada and California, with retail cannabis operations in Illinois. The company owns and manufactures cannabis products under the following brands: HaHa (gummies and beverages), Dreamland (chocolates), TRENDI (vapes and concentrates), Medizin (flower, vapes, concentrates), Leaf and Vine (vapes).
31GF Score
Get the complete analysis for PLNH
Days Sales Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PLNH has been successfully added to your 
